- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The Edge Markets reports that Chinese pharmaceutical group Sinopharm, through a joint venture with GI Healthcare Resources, has agreed to supply 10,000 doses of COVID-19 vaccine for Malaysian ‘frontliners’, especially medical officers and the police.
The Edge Markets continues, “According to GI Healthcare Resources, Sinopharm is currently carrying out Phase III trials on its two vaccine candidates in 10 countries, including the United Arab Emirates (UAE), Bahrain, Egypt, and Morocco, involving over 55,000 subjects. The company said none of the trial participants reported any adverse reactions or side effects.
“Its vaccines have also been approved for emergency use in China, the UAE and Bahrain.
“More than 60,000 personnel who have been vaccinated have gone to work in more than 180 countries overseas without a single reported case of COVID-19 infection.
“GI Healthcare Resources claimed that based on the examples above, Sinopharm's vaccine effectiveness is close to 100%.
"Of the 99 employees in Huawei's Mexico office, 81 were vaccinated and 18 were not vaccinated. After the outbreak, none of the 81 vaccinated employees were infected, whereas 10 out of the 18 employees who were not vaccinated were diagnosed to be COVID-19 positive.”
Additional data provided by
English
Japanese
